Keyphrases
Absolute Growth Rate
7%
Acute Stroke Trial
7%
Change Outcomes
7%
Clinical Outcomes
30%
Cm(III)
7%
Confidence Interval
23%
Diffusion-weighted Imaging
7%
Diffusion-weighted Imaging Lesion
15%
Infarct Growth
100%
Intra-arterial Urokinase
7%
Intravenous Tissue Plasminogen Activator
7%
Ischemic Lesion
7%
Ischemic Lesion Volume
7%
Lesion Growth
38%
Lesion Volume
7%
Long-term Clinical Outcome
100%
Middle Cerebral Artery Territory
7%
Modified Rankin Scale
100%
Multivariate Analysis
7%
National Institutes of Health Stroke Scale (NIHSS)
15%
Odds Ratio
23%
Patients Included
7%
Poor Clinical Outcomes
7%
Poor Outcome
46%
Receiver Operating Characteristic Analysis
7%
Responder Analysis
30%
Surrogate Marker
15%
Thrombolysis
100%
Volume Change
7%
Pharmacology, Toxicology and Pharmaceutical Science
Cerebrovascular Accident
30%
Disease Marker
15%
Infarction
100%
Rankin Scale
100%
Tissue Plasminogen Activator
7%
Urokinase
7%
Neuroscience
Cerebrovascular Accident
100%
Diffusion MRI
75%
Middle Cerebral Artery
25%
Tissue Plasminogen Activator
25%
Urokinase
25%